胡兴胜 - Shanghai Power Equipment Research Institute,Shanghai ,China

基本信息

浏览量：237

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 105 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Ficonalkib (SY-3505) in Advanced ALK-Positive Non-Small-Cell Lung Cancer: A Multicenter, Open-Label, Single-Arm, Phase I/Ⅱ Study

Yuankai Shi,Xingsheng Hu,Xingya Li,Caifeng Gong,Ke Wang,Yongsheng Li,Shucai Zhang,Yongzhong Luo,Pingli Wang,Liyan Jiang,Xiangjiao Meng,Xiaorong Dong,

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (2024)

引用0浏览0WOS引用

Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study

Yuankai Shi,Xingsheng Hu,Xingya Li,Caifeng Gong,Ke Wang,Yongsheng Li,Shucai Zhang,Yongzhong Luo,Pingli Wang,Liyan Jiang,Xiangjiao Meng,Xiaorong Dong,

Journal of Thoracic Oncology (2024)

引用0浏览0引用

Efficacy and safety of SY-3505, a third-generation ALK TKI, in ALK-positive advanced nonsmall cell lung cancer: Results from a phase I/II, multi-center study

Yuankai Shi,Xingsheng Hu,Xingya Li,Yongsheng Li,Ke Wang,Pingli Wang,Liyan Jiang,Shucai Zhang,Xiangjiao Meng,Huijuan Wang,Xiaorong Dong, Runxiang Yang,

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Tumor immune microenvironment in BRAF V600E mutant lung adenocarcinoma

Yutao Liu, Mingzhao Wang, Tong Chen,Weihua Li,Xingsheng Hu,Jun Jiang, Fang Li, Zhiyi Wan,Jie Zhang, Chunmei Zhang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): e21003-e21003

引用0浏览0引用

2188P First-line combination of toripalimab and chemotherapy in advanced thymic carcinoma: A prospective, single-arm, phase II trial

H. Shi, H. Zhu, Y. Feng,Y. Liu, P. Xing,X. Hu

Annals of Oncology (2023): S1132-S1133

引用0浏览0引用

Efficacy and safety of SY-3505, a third-generation ALK TKI, in ALK-positive advanced non-small cell lung cancer: Results from a phase I/II, multi-center study

Yuankai Shi,Xingsheng Hu,Xingya Li,Yongsheng Li,Ke Wang,Pingli Wang,Liyan Jiang,Shucai Zhang,Xiangjiao Meng,Huijuan Wang,Xiaorong Dong,Runxiang Yang,

Journal of Clinical Oncologyno. 16_suppl (2023): 9110-9110

引用0浏览0引用

30 Gy vs. 45 Gy Consolidative Thoracic Radiation (cTRT) for Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Multicenter, Randomized, Phase 3 Trial

N Bi, L Deng,X Hu, G Shayan, L Zhao, L Zhang,W Jiang,J Zhang,X Zhu, Y Wang,H Ge, J Cao,

International journal of radiation oncology, biology, physicsno. 2S (2023): S56-S57

引用0浏览0WOS引用

30P A phase I, dose-escalation and dose-expansion study of SY-3505: A third-generation ALK TKI in Chinese ALK-positive advanced non-small cell lung cancer

Y-K. Shi,X. Hu,X. Li, Y. Li, L. Jiang,S. Zhang, H. Wang,Y. Sun

Annals of Oncology（2022）

引用0浏览0引用

Predictive Value of Peripheral Blood Immune Cell Profiling in EGFR-T790M Mutant Lung Adenocarcinoma

Y. Liu,M. Wang,X. Hu,L. Wang,H. Chen,W. Li, Y. Feng, L. Zhang, G. Yao,Y. Shi

JOURNAL OF THORACIC ONCOLOGY（2022）

引用0浏览0引用

P970: safety and efficacy of bcma-car-t immune cells derived from cord blood in the treatment of relapsed and refractory multiple myeloma

Y. Wang,X. Hu, Q. Gao, H. Wang, Y. Gao,W. Zhang, X. Ru, L. Hou, W. Zhou,H. Zhang, Y. Zhang, F. Wang,

HemaSphere (2022): 860-861

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Xingsheng Hu(胡兴胜)

论文共 105 篇作者统计合作学者相似作者